A PHP Error was encountered

Severity: Notice

Message: Only variable references should be returned by reference

Filename: core/Common.php

Line Number: 257

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: core/Security.php

Line Number: 188

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: libraries/Session.php

Line Number: 672

BIO Magazine - Consuming Coffee Linked to Lower Risk of Detrimental Liver Disease Δεκέμβριος 2015
Δεκέμβριος 2015 No38

BIO News

Consuming Coffee Linked to Lower Risk of Detrimental Liver Disease
Consuming Coffee Linked to Lower Risk of Detrimental Liver Disease

ROCHESTER, Minn. — Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at theDigestive Disease Week 2013 conference in Orlando, Fla.

PSC is an inflammatory disease of the bile ducts that results in inflammation and subsequent fibrosis that can lead to cirrhosis of the liver, liver failure andbiliary cancer .

"While rare, PSC has extremely detrimental effects," says study author Craig Lammert, M.D., a Mayo Clinic gastroenterologist . "We're always looking for ways to mitigate risk, and our first-time finding points to a novel environmental factor that also might help us to determine the cause of this and other devastating autoimmune diseases."

The study examined a large group of U.S. patients with PSC and primary biliary cirrhosis (PBC) and a group of healthy patients. Data showed that coffee consumption was associated with reduced risk of PSC, but not PBC. PSC patients were much likelier not to consume coffee than healthy patients were.The PSC patients also spent nearly 20 percent less of their time regularly drinking coffee than the control.

The study suggests PSC and PBC differ more than originally thought,Konstantinos Lazaridis, M.D. , a Mayo Clinic hepatologist and senior study author says: "Moving forward, we can look at what this finding might tell us about the causes of these diseases and how to better treat them."

The National Institutes of Health funded part of this with a grant to principal investigator Dr. Lazaridis. The American Liver Foundation awarded Dr. Lammert a postdoctoral research fellowship.

http://www.mayoclinic.org/news2013-rst/7466.html

<< Επιστροφή στην λίστα

© BIO | info@biomagazine.gr

Powered by CreativeWorks